These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 1925397
1. [Evans' syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination]. Masson C, Brégeon C, Ifrah N, Berton V, Housseau F, Rénier JC. Rev Rhum Mal Osteoartic; 1991; 58(7):519-22. PubMed ID: 1925397 [Abstract] [Full Text] [Related]
5. Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome. Cervera H, Jara LJ, Pizarro S, Enkerlin HL, Fernandez M, Medina F, Fraga A, Miranda JM. J Rheumatol; 1995 Oct 08; 22(10):1867-71. PubMed ID: 8991983 [Abstract] [Full Text] [Related]
10. [Idiopathic autoimmune hemolytic anemia successfully treated with danazol]. Shinohara K, Okafuji K, Ayame H, Ueda N. Rinsho Ketsueki; 1990 Feb 08; 31(2):256-7. PubMed ID: 2329690 [Abstract] [Full Text] [Related]
11. [Superficial pemphigus during the treatment of rheumatoid polyarthritis with D-penicillamine and piroxicam (Feldene)]. Piette-Brion B, de Bast C, Chamoun E, de Dobbeleer G, André J, Huybrechts A, Ledoux M, Achten G. Dermatologica; 1985 Feb 08; 170(6):297-301. PubMed ID: 4018339 [Abstract] [Full Text] [Related]
12. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment]. Benveniste M, Crouzet J, Homberg JC, Lessana M, Camus JP, Hewitt J. Nouv Presse Med; 1975 Dec 20; 4(44):3125-8. PubMed ID: 1220709 [Abstract] [Full Text] [Related]
13. [Moschcowitz's syndrome following D-penicillamine medication]. Bettendorf U, Pötters R. Med Welt; 1975 Feb 14; 26(7):291-5. PubMed ID: 1168300 [No Abstract] [Full Text] [Related]
14. [The effectiveness of cyclosporin A in the treatment of autoimmune hemolytic anemia and Evans syndrome]. Liu H, Shao Z, Jing L. Zhonghua Xue Ye Xue Za Zhi; 2001 Nov 14; 22(11):581-3. PubMed ID: 11855146 [Abstract] [Full Text] [Related]
15. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine]. Clerc D, Sallière D, Segond P, Bisson M, Massias P. Ann Med Interne (Paris); 1984 Nov 14; 135(6):420-6. PubMed ID: 6334465 [Abstract] [Full Text] [Related]
16. Penicillamine induced mammary hyperplasia: report of a case and review of the literature. Craig HR. J Rheumatol; 1988 Aug 14; 15(8):1294-7. PubMed ID: 3184079 [Abstract] [Full Text] [Related]
17. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis. Hakoda M, Taniguchi A, Kamatani N, Akahoshi T, Kashiwazaki S. J Rheumatol; 1994 Sep 14; 21(9):1637-41. PubMed ID: 7799341 [Abstract] [Full Text] [Related]
18. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study. Weinstein A, Rothfield NF. J Rheumatol; 1986 Apr 14; 13(2):308-12. PubMed ID: 3487646 [Abstract] [Full Text] [Related]